Pregabalin mainstay of treatment in painful diabetic neuropathy

01 Nov 2022
Pregabalin mainstay of treatment in painful diabetic neuropathy
At the recent Novugen Expert Forum, held in Penang, Dr Khaw Chong Hui discussed the prevalence of painful diabetic neuropathy (PDN), role of pregabalin in the treatment of PDN, its place in treatment recommendations of major international pain guidelines and its proven safety and efficacy.
Sponsored as an educational program by Novugen Pharma (Malaysia) Sdn Bhd

Resources

MY-NVG-001

MY-NVG-001

MY-NVG-001

MY-NVG-001